Schisandrol B

Schisandrol B has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 6, 2024: “Schisandrol B inhibits calcification of aortic valve by targeting p53 related inflammatory and senescence”.

Intervention

1 paper studies it5 findingsUpdated

PubChem

None of its findings points the other way.

  • 1 lab in 1 country
  • Funders: National Key Research and Development Program of China and 2 more
  • Animals1

What did studies of Schisandrol B find?

5

Studies of Schisandrol B measured 5 outcomes; the most studied are inflammation (1 study), cellular senescence (1) and calcification (1).

Inflammation

downin cells1

1 study
  1. Schisandrol B inhibits inflammation in cells.

    “thereby promoting p53 ubiquitination and degradation, which further inhibited p53-related inflammatory and senescence response.”

    Cells

    Schisandrol B inhibits calcification of aortic valve by targeting p53 related inflammatory and senescence

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Inflammation

Cellular senescence

downin cells1

1 study
  1. Schisandrol B inhibits cellular senescence in cells.

    “thereby promoting p53 ubiquitination and degradation, which further inhibited p53-related inflammatory and senescence response.”

    Cells

    Schisandrol B inhibits calcification of aortic valve by targeting p53 related inflammatory and senescence

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

More on Cellular senescence

Calcification

downin mice1

1 study
  1. Schisandrol B decreases calcification in mice.

    “In the murine model, SolB significantly decreased the peak velocity of the aortic valve post-injury and reduced valve fibrosis and calcification.”

    Animalspost-wire injuryaortic valve

    Schisandrol B inhibits calcification of aortic valve by targeting p53 related inflammatory and senescence

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Peak velocity

downin mice1

1 study
  1. Schisandrol B decreases peak velocity in mice.

    “In the murine model, SolB significantly decreased the peak velocity of the aortic valve post-injury and reduced valve fibrosis and calcification.”

    Animalspost-wire injuryaortic valve

    Schisandrol B inhibits calcification of aortic valve by targeting p53 related inflammatory and senescence

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Osteogenic differentiation

downin human cells1

1 study
  1. Schisandrol B inhibits osteogenic differentiation in human cells.

    “SolB inhibited the osteogenic differentiation of hVICs, reversing the increase in calcified nodule formation and osteogenic proteins.”

    Cellsosteogenic differentiationaortic valve interstitial cells

    Schisandrol B inhibits calcification of aortic valve by targeting p53 related inflammatory and senescence

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Latest